ArticleJournal of clinical hypertension (Greenwich, Conn.)2025
Outcomes of Successful Versus Failed Stenting in Patients With Unilateral Atherosclerotic Renal Artery Occlusion.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Successful revascularization of chronic total renal artery occlusion in a young patient with resistant hypertension and renal dysfunction: a case report.European heart journal. Case reports · 2026Article
- Comment on "Outcomes of Successful Versus Failed Stenting in Patients With Unilateral Atherosclerotic Renal Artery Occlusion".Journal of clinical hypertension (Greenwich, Conn.) · 2025Article
- Outcomes of Successful Versus Failed Stenting in Patients With Unilateral Atherosclerotic Renal Artery Occlusion.Journal of clinical hypertension (Greenwich, Conn.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Stenting for renal artery occlusion (RAO) remains a subject of considerable debate. We aim to observe whether stenting can improve the clinical outcomes of patients with RAO. Patients with atherosclerotic unilateral RAO and at least 12 months of follow-up were included (n = 42) and were divided into the stenting group (n = 30) and the failed-stenting group (n = 12) based on their surgical outcomes. Blood pressure, serum creatinine, and clinical end point (major adverse cardiovascular or renal events) were recorded. At the last follow-up, there was no significant difference in BP and medication usage between the two groups of patients. Compared with failed revascularization, successful stenting was associated with reduced risk for renal function deterioration (p = 0.035) and clinical end point (p = 0.009). Kaplan-Meier (K-M) analysis showed a benefit of stenting on event-free survival (log-rank p = 0.029) and dialysis-free survival (log-rank p = 0.049). In conclusion, stenting plus medical therapy is effective in slowing the deterioration of renal function and preventing clinical events in patients with atherosclerotic unilateral RAO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.